Drug intelligence / Profile preview

murine interleukin-12-Fc

Development stage
Preclinical
Lead developer
Synthekine
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous, Intraperitoneal
01

Overview

Murine interleukin-12-Fc (mIL-12-Fc) is a recombinant fusion protein consisting of murine interleukin-12 (IL-12) disulfide-linked to an immunoglobulin Fc domain. IL-12 is a proinflammatory cytokine composed of p35 and p40 subunits that binds to the IL-12 receptor complex (IL-12Rβ1 and IL-12Rβ2) on T cells and natural killer (NK) cells. This binding activates the JAK-STAT signaling pathway, specifically JAK2 and TYK2, leading to STAT4 phosphorylation and the robust production of interferon-gamma (IFNγ). The Fc fusion is utilized to extend the typically short half-life of wild-type IL-12, allowing for sustained immune activation. In preclinical research, mIL-12-Fc is used as a wild-type surrogate to study IL-12-mediated anti-tumor responses and systemic toxicities, such as cytokine storms and liver inflammation, which are primarily driven by rapid NK cell activation. It serves as a benchmark for evaluating engineered IL-12 variants with improved therapeutic windows, such as partial agonists.

Other names
murine IL-12-FcmIL-12-IgG FcmIL12-IgG FcmIL 12-IgG Fc
02

Targets

IL12RB2 (Interleukin-12 receptor subunit beta-2)

Beyond the preview

Go deeper on murine interleukin-12-Fc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on murine interleukin-12-Fc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call